Media & Insight
Featured insights
Our news
-
Cooley Partner Honored As Commercial Lawyer of the Year
-
Elizabeth Prelogar Honored With Servant of Justice Award
-
Cooley Signs Lease for New State‑of‑the‑Art Redwood City Office
-
Ajax Therapeutics Acquired By Eli Lilly for $2.3 Billion
-
Cooley Advises BioMarin on $4.25 Billion Financing in Connection With Amicus Therapeutics Acquisition
Media coverage
-
How AI Will Change Services
-
Cooley and BIICL Launch ‘Technology Based Disputes and Investment Treaty Arbitration’ Report
-
$1B Benchmark: US Firms' Quest for UK Growth Marches On Year-on-Year
-
Settlements Slump and Activists Take Fewer Board Seats in First Quarter
-
Litigator of the Week Runners-Up and Shout-Outs
Insights
-
Virginia Enacts Paid Family and Medical Leave Insurance Program
-
Who’s Got That Kind of Time: SEC Shortens Tender Offer Window for Equity Awards in Certain Circumstances
-
What Teva v. Eli Lilly Means for Written Description and Enablement of Method-of-Use Patents
-
Q1 2026 Venture Financing Report
-
State AI Laws – Where Are They Now?
Blogs
-
Should Companies Be Using AI to Draft Their Proxy? An Example to Scare You
-
Cooley Market Talks – AI and the New Capital Dynamic: IPOs, M&A and What Comes Next
-
AI Policy for Fund Managers
-
ICCR Fills the EDGAR Gap By Providing a List of Voluntary Exempt Solicitations
-
Cooley Market Talks – AI and the New Capital Dynamic: IPOs, M&A and What Comes Next